Envista Holdings (NVST) Q2 2026 earnings — TrendMatrix coverage
Reported
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Full disclosure
Key numbers
- Adjusted EPS
- $0.41
- Estimate
- $0.34
- Surprise
- +22.1%
- Revenue (period 2026-07-03)
- $730.5M
- Score today
- 5.9/10
Revenue source: xbrl.
How the report landed
Envista Holdings (NVST) beat the $0.34 estimate with adjusted EPS of $0.41 — a large 22.1% upside surprise.
Where TrendMatrix's rating stands now
TrendMatrix currently rates NVST Hold at 5.9/10; no pre/post engine snapshot brackets this report.
4 of the last 4 quarters beat the estimate; this quarter's +22.1% surprise compares with a +17.7% four-quarter average. Next scheduled report: 2026-11-04.
What supports the rating
- Sector modifier (Healthcare): +0.5
- Strong earnings beat streak (4/4)
What argues against it
- Concentration risk — Geographic: North America (51.0%)
- Concentration risk — Supplier: sole or limited source suppliers
- Negative momentum
This section and the ones below it reflect TrendMatrix’s latest engine read — they update after the report date and are not frozen to it.
The levels TrendMatrix's engine tracks
- Current price
- $22.82
- Price target
- $25.70
- Stop
- $21.66
- Upside to target
- +12.6%
- Reward-to-risk
- 2.5:1
The stock trades at 39.1× trailing but 13.6× forward earnings — consensus estimates already build in a substantial earnings recovery.
Risk check: RSI 29 — a level conventionally read as oversold.
Model outputs from TrendMatrix’s engine as of 2026-10-15 — shown for context, not personalized investment advice.
NVST at TrendMatrix's latest read
Healthcare earnings trade on pipeline and payer dynamics as much as the quarter itself; a beat or miss is weighed against trial and reimbursement news.
- Industry
- Medical Instruments & Supplies
- Market cap
- $3.64B
- P/E (fwd)
- 13.6
- P/E (ttm)
- 39.1
- 52-week range
- $18.77–$30.42
- Off 52-week high
- 25.0%
- RSI (14)
- 29
- Volume vs avg
- 0.71×
- Score today
- 5.9/10